Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Clinical trial NCT01949116 · COMPLETED
Trial details
- NCT number
- NCT01949116
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-31
- Primary completion
- 2016-12-08
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.